WO2025149985 - METHODS OF PREPARING MELANOCORTIN 4 RECEPTOR AGONISTS

National phase entry is expected:
Publication Number WO/2025/149985
Publication Date 17.07.2025
International Application No. PCT/IB2025/050327
International Filing Date 10.01.2025
Title **
[English] METHODS OF PREPARING MELANOCORTIN 4 RECEPTOR AGONISTS
[French] PROCÉDÉS DE PRÉPARATION D'AGONISTES DU RÉCEPTEUR AUX MÉLANOCORTINES DE TYPE 4
Applicants **
LG CHEM, LTD.
PARK, Ae Ri
Inventors
CHOI, Sujin
LEE, Sang Dae
LEE, Soobin
PARK, Jongwon
KIM, Rira
CHO, Kyungseon
CHOI, Inhwan
OH, Moohyun
HAM, Jinok
HONG, Jaehoon
SHIN, Doosup
CHO, Minyong
LEE, Ho Yeon
JUNG, Jae Yeon
PARK, Seongjae
HYUN, Seungmuk
Priority Data
10-2024-0004302   10.01.2024   KR
10-2024-0008338   18.01.2024   KR
10-2024-0008342   18.01.2024   KR
10-2024-0009488   22.01.2024   KR
10-2024-0010985   24.01.2024   KR
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
译文

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting9398
EPO Filing, Examination, Granting294346
Japan Filing, Examination, Granting5660
South Korea Filing, Examination, Granting17440
USA Filing, Examination, Granting69640
MasterCard Visa
Total: 396,484
Contact Us
Abstract[English] The present disclosure features a method for preparing an MC4R agonist and related compositions thereof, such as an MC4R agonist of Formula (I) described herein.[French] La présente invention concerne un procédé de préparation d'un agoniste de MC4R et des compositions associées, tel qu'un agoniste de MC4R de formule (I) décrit ici.